| More and more companies are presently resorting to | | | | converse upon industry specific topics, where visitors |
| formulation and delivery to ensure the success of | | | | will have the ability to partake in the assembly of |
| current and new drug products for the Industry. This | | | | their main area of interest. |
| is due to a general increase in competing firms | | | | The Following topics will be discussed in various |
| throughout the clinical research industry, where New | | | | sessions: |
| Drug Entities have been discovered and the pressure | | | | - Small molecule formulation - enhancing solubility and |
| to produce commercial drugs endure. For the | | | | bioavailability |
| progression and success of current drug products | | | | - Biologic formulation - improving stability and |
| and medicines for the pharmaceutical industry, a vast | | | | preventing aggregation |
| amount of organisations focus on formulation and | | | | - Drug delivery partnerships - evaluating the potential |
| delivery. It is thought that the above has risen from | | | | of new drug delivery technologies |
| an increasing amount of clinical research competitors, | | | | The opportunity to attend these sessions and |
| where new the needs of new commerciall drugs are | | | | network with like-minded peers during this two day |
| on the up and where new drug entities continued to | | | | event will provide attendees with priceless |
| be revealed. | | | | information and facts relating to Drug delivery and |
| World Drug Delivery and Formulation 2010 is an event | | | | formulation. The one-on-one meeting programme |
| that is will be held this year for both scientific and | | | | offers the chance to meet leading specialists and |
| business heads currently involved in formulation and | | | | solution providers in drug formulation and delivery, |
| development to deliberate the obstacles that they | | | | which could provide valuable insight to business |
| are currently facing. | | | | owners who are looking improving working processes |
| Scientific and business professionals from the | | | | back on site. |
| formulation & delivery fields will be able to | | | | |